The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results from the prior treatment cohort of a phase I/II study of nivolumab and axitinib in patients with advanced renal cell carcinoma.
 
Matthew Zibelman
Honoraria - Pfizer
Consulting or Advisory Role - Adicet Bio; AVEO; Exelixis; Merck
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst)
Travel, Accommodations, Expenses - DAVA Oncology
 
Yasser Ged
Consulting or Advisory Role - AVEO; BostonGene; Bristol Myers Squibb; Eisai; Exelixis; Targeted Oncology; Targeted Oncology
 
Michael Carducci
Honoraria - Remedica
Consulting or Advisory Role - Acrivon Therapeutics; AstraZeneca; Pfizer; Sanofi
Research Funding - Arcus Biosciences (Inst); Celgene/Bristol-Myers Squibb (Inst); Merck (Inst); pfizer (Inst)
 
Ana Molina
Consulting or Advisory Role - Eisai; Janssen
 
Rahul Ravilla
Honoraria - Astellas Pharma; Exelixis; Johnson & Johnson/Janssen; Merck
Consulting or Advisory Role - Pfizer/Astellas
Speakers' Bureau - Bristol-Myers Squibb/Celgene; Exelixis; Johnson & Johnson/Janssen; Merck; Pfizer/Astellas
 
Rachel Basiura
No Relationships to Disclose
 
Courtney Lambert
No Relationships to Disclose
 
Madeline Wargins
Employment - Pfizer (I); Seagen (I)
Stock and Other Ownership Interests - Pfizer (I); Seagen (I)
 
Erika Jerome
No Relationships to Disclose
 
Eli Mikkelsen
No Relationships to Disclose
 
Karthik Devarajan
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb
 
Karen Ruth
No Relationships to Disclose
 
Rutika Kokate
No Relationships to Disclose
 
Fern Anari
No Relationships to Disclose
 
Pooja Ghatalia
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb Foundation (Inst); Merck (Inst)
 
Daniel Geynisman
Honoraria - Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Exelixis; Merck; Pfizer; Seattle Genetics/Astellas
Research Funding - Arvinas (Inst); Astellas Pharma (Inst); CG Oncology (Inst); Harpoon therapeutics (Inst); Merck (Inst)
 
Elizabeth Plimack
Consulting or Advisory Role - 23andMe; Abbvie; Adaptimmune; Astellas Pharma; AstraZeneca; Aura Biosciences; Bristol-Myers Squibb/Medarex; Eisai; EMD Serono; Merck; Pfizer; Seagen; Signatera; Synthekine
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst)